TUMOR OVARIUM PREDIKSI

KEGANASAN PRABEDAH
by Nyoman Gede Budiana

FILE T UMOR_OVARIUM_PREDIKSI_KEGANASAN_PRABEDAH.PDF (127.76K)

T IME SUBMIT T ED 31-JUL-2017 09:54PM WORD COUNT 3865
SUBMISSION ID 834292951 CHARACT ER COUNT 22820
TUMOR OVARIUM PREDIKSI KEGANASAN PRABEDAH
GRADEMARK REPORT

FINAL GRADE GENERAL COMMENTS

/0 Instructor

PAGE 1

PAGE 2

PAGE 3

PAGE 4

PAGE 5

PAGE 6

PAGE 7
TUMOR OVARIUM PREDIKSI KEGANASAN PRABEDAH
ORIGINALITY REPORT

15 %
SIMILARIT Y INDEX
%
INT ERNET SOURCES
15%
PUBLICAT IONS
0%
ST UDENT PAPERS

PRIMARY SOURCES

1
Jia, L.-T., Y.-C. Zhang, J. Li, Y. Tian, and J.-F.
Li. "The role of human epididymis protein 4 in
1%
the diagnosis of epithelial ovarian cancer",
Clinical & Translational Oncology, 2015.
Publicat ion

2
Kiuchi, Manabu. "Computer Aided Simulation
of Unsteady Metal Flow in Non-Axisymmetric
1%
Extrusion", CIRP Annals - Manufacturing
Technology, 1988.
Publicat ion

3
Chudecka-Głaz, Anita, Aneta Cymbaluk-
Płoska, Jolanta Jastrzębska, and Janusz
1%
Menkiszak. "Can ROMA algorithm stratify
ovarian tumor patients better when being
based on specific age ranges instead of the
premenopausal and postmenopausal status?",
Tumor Biology, 2016.
Publicat ion

4
Hanna, Calvin, and Katherine P. Wilkinson.
"Effect of idoxuridine on the uptake of tritium-
1%
labeled thymidine in the rabbit cornea infected
 with herpes simplex", Experimental Eye
Research, 1965.
Publicat ion

5
Kaijser, J., A. Sayasneh, K. Van Hoorde, S.
Ghaem-Maghami, T. Bourne, D. Timmerman,
1%
and B. Van Calster. "Presurgical diagnosis of
adnexal tumours using mathematical models
and scoring systems: a systematic review and
meta-analysis", Human Reproduction Update,
2014.
Publicat ion

6
Richard G. Moore. "Evaluation of the
Diagnostic Accuracy of the Risk of Ovarian
1%
Malignancy Algorithm in Women With a Pelvic
Mass :", Obstetrics and Gynecology, 08/2011
Publicat ion

7
Viana, L. S., A. T. Tsunoda, J. S. Nunes, J. H. T.
G. Fregnani, M. A. Vieira, A. K. N. Borges, C. E.
1%
M. d. C. Andrade, and S. V. Serrano.
"Preservation of Pregnancy in a Patient With
Acute Abdominal Pain Secondary to Advanced
and Hemorrhagic Yolk Sac Tumor of the Right
Ovary", Journal of Clinical Oncology, 2011.
Publicat ion

8
Shannon MacLaughlan. "Evaluation and
Management of Women Presenting with a
1%
Pelvic Mass", Current Obstetrics and
 Gynecology Reports, 01/07/2012
Publicat ion

9
Wilailak, Sarikapan, Karen KL Chan, Chi-An
Chen, Joo-Hyun Nam, Kazunori Ochiai, Tar-
1%
Choon Aw, Subathra Sabaratnam, Sudarshan
Hebbar, Jaganathan Sickan, Beth A Schodin,
Chuenkamon Charakorn, and Walfrido W
Sumpaico. "Distinguishing benign from
malignant pelvic mass utilizing an algorithm
with HE4, menopausal status, and ultrasound
findings", Journal of Gynecologic Oncology,
2015.
Publicat ion

10
Kwakkel, G., C.J.T. de Goede, and E.E.H. van
Wegen. "Impact of physical therapy for
1%
Parkinson's disease: A critical review of the
literature", Parkinsonism & Related Disorders,
2007.
Publicat ion

11
Julie M. Jorns. "Occult fallopian tube carcinoma
detected in routine pelvic washing specimens
1%
submitted for staging: Another justification for
pelvic washing cytology?", Diagnostic
Cytopathology, 2009
Publicat ion

12
Arioz, Dagistan Tolga; Yilmaz, Sezgin; Okur,
Nazan; Aktepe, Fatma; Yilmazer, Mehmet and
1%
 Ozalp, Sinan. "Primary Malignant Mixed
Müllerian Tumor of the Fimbriated End of the
Fallopian Tube Causing Hematosalpinx and
Hematometra", North American Journal of
Medical Sciences, 2012.
Publicat ion

13
Marcus Q Bernardini. "Expression signatures of
TP53 mutations in serous ovarian cancers",
<1%
BMC Cancer, 2010
Publicat ion

14
Thanapprapasr, Duangmani, and Sarikapan
Wilailak. "Screening for Ovarian Cancer in
<1%
Women", Ovarian Cancer - Clinical and
Therapeutic Perspectives, 2012.
Publicat ion

15
James H. Liu. "Management of the Adnexal
Mass :", Obstetrics and Gynecology, 06/2011
<1%
Publicat ion

16
Lin, Jia-Ying, Jin-Bao Qin, Xiao-Yan Li, Ping
Dong, and Bing-De Yin. "Diagnostic Value of
<1%
Human Epididymis Protein 4 Compared with
Mesothelin for Ovarian Cancer: a Systematic
Review and Meta-analysis", Asian Pacific
Journal of Cancer Prevention, 2012.
Publicat ion

17
D. SZPUREK. "Using logistic regression
analysis in preliminary differential diagnosis of
<1%
 adnexal masses", International Journal of
Gynecological Cancer, 9/2005
Publicat ion

18
Britton, K, and M Granowska. "Gynecological
cancer", Clinical Nuclear Medicine Fourth
<1%
Edition, 2006.
Publicat ion

19
Lin, H.-H., K. Kawakami, and H. Kudo. "Metal
Flow Control in Cold Simultaneous
<1%
Forward/Backward Extrusion", CIRP Annals -
Manufacturing Technology, 1988.
Publicat ion

20
Sarkar, Manisha, Tulika Jha, Tushar Das,
Vidyasagar Sau, Sukla Mitra, and Kuntal Roy.
<1%
"Spectrum of epithelial ovarian tumors with
HER2/neu expression by the carcinomas
among patients admitted in a tertiary care
hospital in Eastern India", International Journal
of Medical Science and Public Health, 2015.
Publicat ion

21
Zhang, Pengjun, Chuanxin Wang, Liming
Cheng, Peng Zhang, Lin Guo, Wanli Liu,
<1%
Zhongying Zhang, Yanchun Huang, Qishui Ou,
Xinyu Wen, and Yaping Tian. "Development of
a multi-marker model combining HE4, CA125,
progesterone, and estradiol for distinguishing
benign from malignant pelvic masses in
 postmenopausal women", Tumor Biology,
2015.
Publicat ion

22
OBARA, TAKAO, YOSHIHIDE FUJIMOTO,
YUKIO ITO, TAKAYA KODAMA, YOSHIHARU
<1%
KANAJI, TAKAHIRO OKAMOTO, YUJI
TAKAHASH, TSUNEHIRO NISHI, and AKIRA
HIRAYAMA. "Functioning Parathyroid
Lipoadenoma. Report of Four Cases:
Clinicopathological and Ultrasonographic
Features.", Endocrinologia Japonica, 1989.
Publicat ion

23
"Intraoperative frozen section analysis for the
diagnosis of early stage ovarian cancer in
<1%
suspicious pelvic masses", Cochrane Database
of Systematic Reviews, 2016.
Publicat ion

24
Wei, Su, Hui Li, and Bei Zhang. "The diagnostic
value of serum HE4 and CA-125 and ROMA
<1%
index in ovarian cancer", Biomedical Reports,
2016.
Publicat ion

25
Chen, Wen-Ting, Xiang Gao, Xiao-Dian Han,
Hui Zheng, Lin Guo, and Ren-Quan Lu. "HE4
<1%
as a Serum Biomarker for ROMA Prediction
and Prognosis of Epithelial Ovarian Cancer",
Asian Pacific Journal of Cancer Prevention,
 2014.
Publicat ion

26
Chan, Karen K.L., Chi-An Chen, Joo-Hyun
Nam, Kazunori Ochiai, Sarikapan Wilailak, Aw-
<1%
Tar Choon, Subathra Sabaratnam, Sudarshan
Hebbar, Jaganathan Sickan, Beth A. Schodin,
and Walfrido W. Sumpaico. "The use of HE4 in
the prediction of ovarian cancer in Asian
women with a pelvic mass", Gynecologic
Oncology, 2013.
Publicat ion

27
Su, Zengliu, Whitney S. Graybill, and Yusheng
Zhu. "Detection and monitoring of ovarian
<1%
cancer", Clinica Chimica Acta, 2013.
Publicat ion

28
Deshmukh, Jeevanand; Kulkarni, Vinaya
Kumar; Katti, Girish and Deshpande, Sachin.
<1%
"Pyogenic Granuloma, An Unusual
Presentation In Pediatric Patient - A Case
Report", Indian Journal of Dental Sciences,
2013.
Publicat ion

29
F. G. Tinelli. "Pregnancy outcome and
recurrence after conservative laparoscopic
<1%
surgery for borderline ovarian tumors", Acta
Obstetricia Et Gynecologica Scandinavica,
2007
Publicat ion
30
Advances in Diagnosis and Management of
Ovarian Cancer, 2014.
<1%
Publicat ion

31
Al-Musalhi , Khawla | Al-Kindi , Manal |
Ramadhan , Fatma | Al-Rawahi , Thuraya | Al-
<1%
Hatali , Khalsa | Mula-Abed , Waad-Allah.
"Validity of Cancer Antigen - 125 ( CA - 125 )
and Risk of Malignancy Index ( RMI ) in the
Diagnosis of Ovarian Cancer", Oman Medical
Specialty Board, 2015.
Publicat ion

EXCLUDE QUOT ES ON EXCLUDE MAT CHES OFF

EXCLUDE OFF
BIBLIOGRAPHY